Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.48 |
| ▸ | DRD3 | P35462 | 2/20 | 0.48 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 5/20 | 0.36 |
| ▸ | HTR2C | P28335 | 3/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | BPTF | Q12830 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7847793 | 1.00 | DRD2 (0.48) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| SCHEMBL6245152 | 1.00 | DRD2 (0.48) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| SCHEMBL29960480 | 1.00 | DRD2 (0.48) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| SCHEMBL7846711 | 1.00 | DRD2 (0.48) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL8686016 | 0.98 | DRD2 (0.47) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL8903758 | 0.98 | DRD2 (0.47) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL29960743 | 0.98 | DRD2 (0.47) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL29960383 | 0.98 | DRD2 (0.47) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| SCHEMBL12649085 | 0.87 | DRD2 (0.45) | DRD2DRD3SSTR4CHRNB4CHRNA3 | |
| SCHEMBL8528971 | 0.85 | DRD2 (0.44) | DRD2DRD3SSTR4LTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0942911-B1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | ABBOTT LAB (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6046207-A | FOR INHIBITING ALPHA-1 ADRENORECEPTORS AND TREATING BENIGN PROSTATIC HYPERPLASIA, ALSO CALLED BENIGN PROSTATIC HYPERTROPHY, OR OTHER UROLOGICAL OR GYNECOLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION, NEUROGENIC BLADDER | ABBOTT LABORATORIES | 2000-04-04 | — | — | US | disclosed |
| US-5891882-A | TREATING BENIGN PROSTATIC HYPERPLASIA OR OTHER UROLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION AND NEUROGENIC BLADDER, OR GYNECOLOGICAL SYNDROMES SUCH AS DYSMENORRHEA | ABBOTT LABORATORIES (US) | 1999-04-06 | — | — | US | disclosed |
| US-5723484-A | Benzopyran compounds as 5-HT2C receptor antagonists | ADIR ET COMPAGNIE (FR) | 1998-03-03 | — | — | US | disclosed |